Valuation: Unichem Laboratories Limited

Market Cap 38.74B 404M 355M 335M 305M 571M 575M 4.01B 1.55B 19.79B 1.52B 1.48B 63.6B P/E 2025
35.6x
P/E 2026 8.19x
Enterprise Value 40.84B 426M 374M 353M 322M 602M 607M 4.23B 1.64B 20.87B 1.6B 1.57B 67.06B EV / Sales 2025
2.49x
EV / Sales 2026 1.03x
Free-Float
28.74%
Yield 2025 *
-
Yield 2026 -
1 day-0.53%
1 week+0.73%
Current month-1.23%
1 month+3.66%
3 months+26.95%
6 months+84.03%
Current year+24.41%
1 week 521.55
Extreme 521.55
582
1 month 497.8
Extreme 497.8
591.25
Current year 278.2
Extreme 278.2
687.2
1 year 278.2
Extreme 278.2
687.2
3 years 278.2
Extreme 278.2
937.95
5 years 198
Extreme 198
937.95
10 years 80
Extreme 80
937.95
Manager TitleAgeSince
Chief Executive Officer 57 09/08/2023
Director of Finance/CFO - 07/08/2024
Compliance Officer - -
Director TitleAgeSince
Chairman 73 21/08/1977
Director/Board Member 53 09/08/2023
Director/Board Member 57 09/08/2023
Change 5-day change 1-year change 3-year change Capi.($)
-0.53%+0.73% - - 404M
+0.13%+2.65%+63.34%+115.17% 1,055B
+0.20%+0.46%+50.92%+70.56% 654B
-0.29%+0.14%+19.82%+71.75% 467B
-0.85%+0.98%+42.13%+44.64% 348B
+0.71%+4.08%+21.75%+28.83% 275B
+1.23%+0.42%+14.11%+12.43% 258B
+2.11%+7.51%+51.88%+54.11% 224B
+0.83%+0.55%+34.64%+99.83% 187B
0.00%-10.14%-27.40%-61.08% 171B
Average +0.35%+0.74%+30.13%+48.47% 404.26B
Weighted average by Cap. +0.27%+1.32%+40.43%+68.22%

Financials

2025 2026
Net sales 21.11B 220M 193M 183M 166M 311M 314M 2.18B 846M 10.78B 827M 809M 34.66B 22.02B 230M 202M 190M 174M 325M 327M 2.28B 882M 11.25B 863M 844M 36.15B
Net income 1.38B 14.35M 12.59M 11.89M 10.84M 20.29M 20.43M 142M 55.11M 703M 53.87M 52.71M 2.26B 2.53B 26.38M 23.15M 21.86M 19.92M 37.3M 37.56M 262M 101M 1.29B 99.05M 96.91M 4.15B
Net Debt 3.7B 38.62M 33.89M 32.01M 29.17M 54.61M 55M 383M 148M 1.89B 145M 142M 6.08B 2.11B 21.98M 19.29M 18.22M 16.6M 31.08M 31.3M 218M 84.43M 1.08B 82.53M 80.74M 3.46B
Logo Unichem Laboratories Limited
Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.
Employees
2,780
Date Price Change Volume
25/09/26 ₹549.70 -0.53% 50,490
24/09/26 ₹552.65 -3.59% 156,065
23/09/26 ₹573.20 +6.39% 294,887
22/09/26 ₹538.75 -0.35% 114,861
21/09/26 ₹540.65 -0.93% 72,661